Predicting risk factors for hypothyroidism after definitive radiotherapy for early glottic carcinomas

被引:0
|
作者
Okubo, Mitsuru [1 ,3 ]
Itonaga, Tomohiro [1 ]
Saito, Tatsuhiko [1 ]
Yunaiyama, Daisuke [1 ]
Mikami, Ryuji [1 ]
Okada, Yukinori [1 ]
Sugahara, Shinji [1 ]
Kondo, Takahito [2 ]
Tokuuye, Koichi [1 ]
Saito, Kazuhiro [1 ]
机构
[1] Tokyo Med Univ Hosp, Dept Radiol, Tokyo 1600023, Japan
[2] Tokyo Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Hachioji Med Ctr, Tokyo 1930998, Japan
[3] Tokyo Med Univ Hosp, Dept Radiol, 6-7-1 Nishishinjuku, Tokyo, Tokyo 1600023, Japan
关键词
glottic carcinomas; hypothyroidism; laryngeal carcinoma; radiotherapy; thyroid gland; RADIATION-INDUCED HYPOTHYROIDISM; NECK-CANCER-PATIENTS; SUBCLINICAL HYPOTHYROIDISM; DOSIMETRIC PREDICTORS; HEAD; THERAPY;
D O I
10.3892/ol.2022.13603
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hypothyroidism may occur after definitive radiotherapy in rare cases of early glottic carcinoma. However, to the best of our knowledge, no study to date has examined the risk factors for hypothyroidism specifically after definitive radiotherapy in patients with early glottic carcinoma. The present study determined risk factors for hypothyroidism after definitive radiotherapy in patients with early glottic carcinoma. This was a retrospective study that included 73 patients with T1 or T2, N0 glottic squamous cell carcinoma who underwent radiotherapy between June 3, 2009 and December 25, 2020. Demographic and clinical characteristics, including age, sex, tumor stage and pretreatment thyroid volume, were examined to elucidate the clinical risk factors for hypothyroidism. Field size, total prescribed dose and thyroid receiving dose were evaluated as dosimetric risk factors for hypothyroidism. Irradiated underlying thyroid volumes of more than 5, 10, 20, 30, 40, 50, 60 and 65 Gy (V5Gy, V10Gy, V20Gy, V30Gy, V40Gy, V50Gy, V60Gy and V65Gy) and mean thyroid dose were included as thyroid receiving doses. The median follow-up duration was 61 months (range, 7-150 months). Hypothyroidism was present in 15 (21%) of the 73 patients, including 12 and 3 patients with grade 1 and 2 hypothyroidism, respectively. Among the demographic and clinical factors, sex and pretreatment thyroid volume were significantly associated with hypothyroidism (P=0.007 and P<0.001, respectively). Among the dosimetric factors, the presence of hypothyroidism was significantly associated with V5Gy (P=0.012), V10Gy (P=0.015), V20Gy (P=0.020), V30Gy (P=0.024), V40Gy (P=0.028), V50Gy (P=0.028), V60Gy (P=0.027) and mean thyroid dose (P=0.023). In conclusion, sex, pretreatment thyroid volume and thyroid receiving dose were associated with hypothyroidism after definitive radiotherapy in patients with early glottic carcinoma. Particularly, the receiving dose to the thyroid gland should be reduced in female patients and in those with small thyroid volumes who are at higher risk for hypothyroidism following radiotherapy.
引用
下载
收藏
页数:6
相关论文
共 50 条
  • [31] Clinical Characteristics and Prognostic Factors of Early and Late Recurrence After Definitive Radiotherapy for Nasopharyngeal Carcinoma
    Li, Feng
    Chen, Fo-Ping
    Chen, Yu-Pei
    Chen, Yue
    He, Xiao-Jun
    Huang, Xiao-Dan
    Zheng, Zi-Qi
    Zheng, Wei-Hong
    Liu, Xu
    Sun, Ying
    Zhou, Guan-Qun
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [32] VOCAL QUALITY 10 YEARS AFTER RADIOTHERAPY FOR EARLY GLOTTIC CANCER
    MARSH, LF
    ROBINSON, HF
    MORGAN, DAL
    BRITISH JOURNAL OF RADIOLOGY, 1987, 60 (716): : 827 - 827
  • [33] Multidimensional assessment of voice characteristics after radiotherapy for early glottic cancer
    Verdonck-de Leeuw, IM
    Hilgers, FJM
    Keus, RB
    Koopmans-van Beinum, FJ
    Greven, AJ
    de Jong, JMA
    Vreeburg, G
    Bartelink, H
    LARYNGOSCOPE, 1999, 109 (02): : 241 - 248
  • [34] CCI and TNM stage do not influence early mortality risk after definitive radiotherapy in NSCLC
    Jensen, K. H.
    Friborg, J.
    Vogelius, I. R.
    Pohl, M.
    Frank, M. S.
    Hansen, O.
    Schytte, T.
    Kristiansen, C.
    Knap, M.
    Skovborg, M.
    McCulloch, T.
    Persson, G.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S326 - S327
  • [35] Risk factors for neurodevelopmental deficits in congenital hypothyroidism after early substitution treatment
    Huo, Kaiming
    Zhang, Zhan
    Zhao, Dehua
    Li, Hezhou
    Wang, Jun
    Wang, Xinxia
    Feng, Hongqi
    Wang, Xiaoyang
    Zhu, Changlian
    ENDOCRINE JOURNAL, 2011, 58 (05) : 355 - 361
  • [36] Hypothyroidism after radiotherapy in childhood and adolescence: Risk data
    Boelling, T.
    Geisenheiser, A.
    Ernst, I.
    Pape, H.
    Martini, C.
    Ruebe, C.
    Timmermann, B.
    Fischedick, K.
    Kortmann, R. -D.
    Willich, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2010, 186 : 88 - 89
  • [37] Pelvic fractures after definitive and postoperative radiotherapy for cervical cancer: A retrospective analysis of risk factors
    Yamamoto, Kasumi
    Nagao, Shoji
    Suzuki, Kazuhiro
    Kogiku, Ai
    Senda, Tokihiro
    Yano, Hiroko
    Kitai, Miho
    Shiozaki, Takaya
    Matsuoka, Kazuko
    Yamaguchi, Satoshi
    GYNECOLOGIC ONCOLOGY, 2017, 147 (03) : 585 - 588
  • [38] Bone Injury after Definitive Radiotherapy for Uterine Cervical Cancer: Retrospective Analysis of Risk Factors
    Uezono, H.
    Tsujino, K.
    Moriki, K.
    Matsumoto, Y.
    Nagano, F.
    Ota, Y.
    Sugimura, K.
    Sasaki, R.
    Soejima, T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S461 - S461
  • [39] Radiotherapy of early-stage glottic cancer: Analysis of factors affecting prognosis
    Chen, MF
    Chang, JTC
    Tsang, NM
    Liao, CT
    Chen, WC
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2003, 112 (10): : 904 - 911
  • [40] Clinical results and prognostic factors in radiotherapy for early glottic squamous cell carcinoma
    Nomiya, T.
    Kuroda, Y.
    Suzuki, M.
    Murakami, M.
    Wada, H.
    Nemoto, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 479 - 479